Lineage Cell Therapeutics, Inc. (LCTX)
+0.020 (1.89%)
May 17, 2024, 4:00 PM EDT - Market closed

Lineage Cell Therapeutics Revenue

Lineage Cell Therapeutics had revenue of $8.00M in the twelve months ending March 31, 2024, down -32.48% year-over-year. Revenue in the quarter ending March 31, 2024 was $1.44M, a -39.48% decrease year-over-year. In the year 2023, Lineage Cell Therapeutics had annual revenue of $8.95M, a decrease of -39.16%.

Revenue (ttm)
Revenue Growth
P/S Ratio
Revenue / Employee
Market Cap
203.90M USD

Revenue Chart


Fiscal Year End Revenue Change Growth
Dec 31, 20238.95M-5.76M-39.16%
Dec 31, 202214.70M10.36M238.70%
Dec 31, 20214.34M2.52M137.73%
Dec 31, 20201.83M-1.69M-48.05%
Dec 31, 20193.52M-1.47M-29.53%
Dec 31, 20184.99M1.53M44.25%
Dec 31, 20173.46M-2.47M-41.62%
Dec 31, 20165.92M-1.11M-15.82%
Dec 31, 20157.04M1.79M34.17%
Dec 31, 20145.24M810.00K18.27%
Dec 31, 20134.43M518.67K13.25%
Dec 31, 20123.92M-518.83K-11.70%
Dec 31, 20114.43M726.14K19.58%
Dec 31, 20103.71M1.78M92.61%
Dec 31, 20091.93M421.38K28.02%
Dec 31, 20081.50M457.67K43.75%
Dec 31, 20071.05M-115.89K-9.97%
Dec 31, 20061.16M258.82K28.66%
Dec 31, 2005903.20K214.82K31.21%
Dec 31, 2004688.38K131.96K23.71%
Dec 31, 2003556.42K169.40K43.77%
Dec 31, 2002387.02K235.10K154.76%
Dec 31, 2001151.92K99.43K189.41%
Dec 31, 200052.49K-985.01K-94.94%
Dec 31, 19991.04M-112.50K-9.78%
Jun 30, 19981.15M1.09M1,740.00%
Dec 31, 199762.50K--
Dec 31, 19960--
Jun 30, 19950--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Butterfly Network 68.08M
AVITA Medical 51.50M
Zevra Therapeutics 28.01M
Capricor Therapeutics 27.10M
Inventiva 25.74M
bluebird bio 21.73M
Veru Inc. 13.48M
Delcath Systems 4.61M
Revenue Rankings